ArticleJournal of experimental & clinical cancer research : CR2022

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion.

Yanyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.